1. Home
  2. ALCYU vs CERT Comparison

ALCYU vs CERT Comparison

Compare ALCYU & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALCYU
  • CERT
  • Stock Information
  • Founded
  • ALCYU N/A
  • CERT 2008
  • Country
  • ALCYU
  • CERT United States
  • Employees
  • ALCYU 3
  • CERT N/A
  • Industry
  • ALCYU
  • CERT Retail: Computer Software & Peripheral Equipment
  • Sector
  • ALCYU
  • CERT Technology
  • Exchange
  • ALCYU NYSE
  • CERT Nasdaq
  • Market Cap
  • ALCYU N/A
  • CERT 1.9B
  • IPO Year
  • ALCYU N/A
  • CERT 2020
  • Fundamental
  • Price
  • ALCYU $10.98
  • CERT $10.71
  • Analyst Decision
  • ALCYU
  • CERT Buy
  • Analyst Count
  • ALCYU 0
  • CERT 7
  • Target Price
  • ALCYU N/A
  • CERT $15.92
  • AVG Volume (30 Days)
  • ALCYU N/A
  • CERT 1.4M
  • Earning Date
  • ALCYU N/A
  • CERT 11-06-2024
  • Dividend Yield
  • ALCYU N/A
  • CERT N/A
  • EPS Growth
  • ALCYU N/A
  • CERT N/A
  • EPS
  • ALCYU N/A
  • CERT N/A
  • Revenue
  • ALCYU N/A
  • CERT $372,797,000.00
  • Revenue This Year
  • ALCYU N/A
  • CERT $10.20
  • Revenue Next Year
  • ALCYU N/A
  • CERT $10.43
  • P/E Ratio
  • ALCYU N/A
  • CERT N/A
  • Revenue Growth
  • ALCYU N/A
  • CERT 5.62
  • 52 Week Low
  • ALCYU N/A
  • CERT $9.41
  • 52 Week High
  • ALCYU N/A
  • CERT $19.87
  • Technical
  • Relative Strength Index (RSI)
  • ALCYU 46.01
  • CERT 45.72
  • Support Level
  • ALCYU $11.07
  • CERT $10.31
  • Resistance Level
  • ALCYU $11.10
  • CERT $11.77
  • Average True Range (ATR)
  • ALCYU 0.00
  • CERT 0.58
  • MACD
  • ALCYU -0.00
  • CERT -0.07
  • Stochastic Oscillator
  • ALCYU 0.00
  • CERT 26.32

About ALCYU ALCHEMY INVTS ACQUISITION CORP 1 UNIT 1 CL A COM & 1/2 WT

Alchemy Investments Acquisition Corp 1 is a blank check company.

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Share on Social Networks: